Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA.
(Image credit: MirageC/Getty Images)
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics from NPR Will Stone
